Moreno Daniel Antunes, Bonatelli Murilo, Antoniazzi Augusto Perazzolo, de Paula Flávia Escremim, Leal Leticia Ferro, Garcia Felipe Antônio de Oliveira, de Paula André Escremim, Teixeira Gustavo Ramos, Santana Iara Viana Vidigal, Saggioro Fabiano, Neder Luciano, Valera Elvis Terci, Scrideli Carlos Alberto, Stavale João, Malheiros Suzana Maria Fleury, Lima Matheus, Hajj Glaucia Noeli Maroso, Garcia-Rivello Hernan, Christiansen Silvia, Nunes Susana, Gil-da-Costa Maria João, Pinheiro Jorge, Martins Flavia Delgado, Junior Carlos Almeida, Mançano Bruna Minniti, Reis Rui Manuel
Molecular Oncology Research Center, Barretos Cancer Hospital, Barretos, Brazil.
Molecular Diagnosis Laboratory, Barretos Cancer Hospital, Barretos, Brazil.
Front Oncol. 2023 Sep 4;13:1237170. doi: 10.3389/fonc.2023.1237170. eCollection 2023.
Medulloblastomas are the most common primary malignant brain tumors in children. They are divided into molecular subgroups: WNT-activated, SHH-Activated, mutant or wild type, and non-WNT/non-SHH (Groups 3 and 4). WNT-activated medulloblastomas are usually caused by mutations in the gene (85%-90%), and most remaining cases wild type are thought to be caused by germline mutations in . So far, the frequencies of have been reported mainly in North American and European populations. The aim of this study was to report the frequency of mutations in WNT-activated medulloblastomas in a Latin-Iberian population and correlate with their clinicopathological characteristics.
A total of 266 medulloblastomas from seven different institutions from Brazil (n=211), Portugal (n=38), and Argentina (n=17) were evaluated. Following RNA and DNA isolation from formalin-fixed, paraffin-embedded (FFPE) tumor tissues, the molecular classification and mutation analysis were performed by nCounter and Sanger sequencing, respectively.
WNT-activated medulloblastomas accounted for 15% (40/266) of the series. We observed that 73% of WNT-activated medulloblastomas harbored mutations. wild-type cases (27%) were more prevalent in female individuals and suggested to be associated with a worse outcome. Among the wild-type cases, the available analysis of family history revealed two cases with familiar adenomatous polyposis, harboring germline variants.
We observed a lower incidence of mutations in WNT-activated medulloblastomas in our Latin-Iberian cohort compared to frequencies previously described in other populations. Considering that wild-type cases may exhibit germline mutations, our study suggests a higher incidence (~30%) of hereditary WNT-activated medulloblastomas in the Latin-Iberian population.
髓母细胞瘤是儿童最常见的原发性恶性脑肿瘤。它们被分为分子亚组:WNT激活型、SHH激活型、突变型或野生型,以及非WNT/非SHH(3组和4组)。WNT激活型髓母细胞瘤通常由 基因的突变引起(85%-90%),其余大多数野生型病例被认为是由 中的种系突变引起。到目前为止, 的频率主要在北美和欧洲人群中报道。本研究的目的是报告拉丁-伊比利亚人群中WNT激活型髓母细胞瘤中 突变的频率,并将其与临床病理特征相关联。
对来自巴西(n=211)、葡萄牙(n=38)和阿根廷(n=17)七个不同机构的266例髓母细胞瘤进行评估。从福尔马林固定、石蜡包埋(FFPE)肿瘤组织中分离RNA和DNA后,分别通过nCounter和Sanger测序进行分子分类和 突变分析。
WNT激活型髓母细胞瘤占该系列的15%(40/266)。我们观察到73%的WNT激活型髓母细胞瘤存在 突变。野生型病例(27%)在女性个体中更为普遍,并且提示与更差的预后相关。在野生型病例中,对家族史的现有分析显示有两例患有家族性腺瘤性息肉病,携带 种系变异。
与先前在其他人群中描述的频率相比,我们在拉丁-伊比利亚队列中观察到WNT激活型髓母细胞瘤中 突变的发生率较低。考虑到野生型病例可能存在 种系突变,我们的研究表明拉丁-伊比利亚人群中遗传性WNT激活型髓母细胞瘤的发生率较高(约30%)。